Bleeding risk from anticoagulant thromboprophylaxis in patients with multiple myeloma: a MarketScan analysis.

Res Pract Thromb Haemost · 2024 · PMC11127259 · PMID 38798793

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

A significant trend showed that DOACs are increasingly prescribed as anticoagulant thromboprophylaxis over warfarin and LMWH in recent years.

also in 9,774 other papers

a notable trendno p-value reported

There was a notable trend over time in favor of DOACs as the preferred anticoagulant prescribed, while warfarin utilization was minimal later in the study period.

also in 2,380 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.